Search Results - "Seo, Mikyung Kelly"
-
1
Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer
Published in PloS one (26-09-2018)“…Recent advances in targeted therapies have raised expectations that the clinical application of biomarkers would improve patient's health outcomes and…”
Get full text
Journal Article -
2
How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review
Published in BMC cancer (01-09-2021)“…Abstract Background Despite the increasing economic assessment of biomarker-guided therapies, no clear agreement exists whether existing methods are sufficient…”
Get full text
Journal Article -
3
Has the development of cancer biomarkers to guide treatment improved health outcomes?
Published in The European journal of health economics (01-07-2021)“…During the last decade, testing the patient’s biomarker status prior to the administration of corresponding co-dependent therapies has been emerging in…”
Get full text
Journal Article -
4
A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper
Published in PharmacoEconomics (01-12-2021)“…Despite the increasing number of potential biomarkers identified in laboratories and reported in much literature, the adoption of biomarkers routinely…”
Get full text
Journal Article -
5
Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?
Published in PharmacoEconomics (01-06-2024)“…Objectives Accurate risk stratification of patients with stage II and III colorectal cancer (CRC) prior to treatment selection enables limited health resources…”
Get full text
Journal Article -
6
The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE’s New Methods Manual
Published in Value in health (01-10-2023)“…The National Institute for Health and Care Excellence (NICE) recently completed a review of its methods for health technology assessment, involving a 2-stage…”
Get full text
Journal Article -
7
Is point-of-care testing feasible and safe in care homes in England? An exploratory usability and accuracy evaluation of a point-of-care polymerase chain reaction test for SARS-CoV-2
Published in Age and ageing (11-09-2021)“…Reliable rapid testing for COVID-19 is needed in care homes to reduce the risk of outbreaks and enable timely care. This study aimed to examine the usability…”
Get full text
Journal Article -
8
Reply to comment on “Demonstrating the value of cancer biomarkers at the population”
Published in The European journal of health economics (01-06-2022)Get full text
Journal Article -
9
HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?
Published in PharmacoEconomics - open (01-09-2020)“…Background Despite the extensive use of bevacizumab in a range of oncology indications, the US FDA revoked its approval for breast cancers, and multiple…”
Get full text
Journal Article -
10
Cost-effectiveness analysis of vaccinating children in Malawi with RTS,S vaccines in comparison with long-lasting insecticide-treated nets
Published in Malaria journal (24-02-2014)“…New RTS,S malaria vaccines may soon be licensed, yet its cost-effectiveness is unknown. Before the widespread introduction of RTS,S vaccines,…”
Get full text
Journal Article